Yifan Xinfu Pharmaceutical Co Ltd (002019) — Cash Flow Reinvestment Rate
Yifan Xinfu Pharmaceutical Co Ltd (002019) has a Cash Flow Reinvestment Rate of 4.60x as of September 2025, reinvesting CN¥184.68 Million (capex CN¥184.68 Million ) from operating cash flow of CN¥40.18 Million. Check how high is Yifan Xinfu Pharmaceutical Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Yifan Xinfu Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Yifan Xinfu Pharmaceutical Co Ltd across 21 annual periods. Explore investment intensity of Yifan Xinfu Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Yifan Xinfu Pharmaceutical Co Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Yifan Xinfu Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Yifan Xinfu Pharmaceutical Co Ltd (002019) total market value.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.40x | CN¥639.96 Million | CN¥458.37 Million | CN¥559.23 Million | ▲ +26.7% |
| 2024 | 1.10x | CN¥705.83 Million | CN¥640.73 Million | CN¥628.16 Million | ▼ -63.0% |
| 2023 | 2.97x | CN¥1.04 Billion | CN¥348.58 Million | CN¥504.09 Million | ▲ +15.8% |
| 2022 | 2.57x | CN¥1.21 Billion | CN¥472.07 Million | CN¥542.27 Million | ▲ +21.2% |
| 2021 | 2.12x | CN¥638.34 Million | CN¥301.23 Million | CN¥571.74 Million | ▲ +216.7% |
| 2020 | 0.67x | CN¥741.71 Million | CN¥1.11 Billion | CN¥715.71 Million | ▼ -34.2% |
| 2019 | 1.02x | CN¥952.57 Million | CN¥937.24 Million | CN¥866.07 Million | ▼ -7.3% |
| 2018 | 1.10x | CN¥1.28 Billion | CN¥1.17 Billion | CN¥729.21 Million | ▲ +17.4% |
| 2017 | 0.93x | CN¥1.06 Billion | CN¥1.13 Billion | CN¥485.86 Million | ▼ -39.4% |
| 2016 | 1.54x | CN¥1.32 Billion | CN¥855.85 Million | CN¥287.50 Million | ▲ +131.9% |
| 2015 | 0.66x | CN¥267.15 Million | CN¥401.96 Million | CN¥217.15 Million | ▲ +3.8% |
| 2014 | 0.64x | CN¥89.51 Million | CN¥139.74 Million | CN¥89.51 Million | ▼ -70.3% |
| 2013 | 2.15x | CN¥73.95 Million | CN¥34.32 Million | CN¥73.95 Million | ▼ -4.8% |
| 2012 | 2.26x | CN¥67.64 Million | CN¥29.88 Million | CN¥67.64 Million | ▼ -12.3% |
| 2009 | 2.58x | CN¥151.27 Million | CN¥58.61 Million | CN¥151.27 Million | ▲ +75.6% |
| 2008 | 1.47x | CN¥122.46 Million | CN¥83.31 Million | CN¥122.46 Million | ▲ +112.5% |
| 2007 | 0.69x | CN¥172.06 Million | CN¥248.71 Million | CN¥172.06 Million | ▼ -60.8% |
| 2006 | 1.77x | CN¥57.62 Million | CN¥32.62 Million | CN¥57.62 Million | ▼ -27.3% |
| 2005 | 2.43x | CN¥58.63 Million | CN¥24.12 Million | CN¥58.63 Million | ▲ +16.4% |
| 2004 | 2.09x | CN¥70.14 Million | CN¥33.59 Million | CN¥70.14 Million | ▼ -49.6% |
| 2003 | 4.14x | CN¥52.44 Million | CN¥12.65 Million | CN¥52.44 Million | — |